1. Julie Schanz is Consultant Hematologist and Oncologist at the University of Goettingen (Germany). The Cytogenetic Work Group of the Department of Hematology and Oncology has great experience in the cytogenetics of hematologic diseases, especially the prognostic classification of cytogenetic abnormalities in myelodysplastic syndromes (MDS). She is a member of the International Working Group for the Prognosis of MDS.
2. Detlef Haase has been Director of the Tumor Cytogenetics Laboratory of the Laboratory for Specialized Hematologic Diagnostics at the Department of Haemotology and Oncology, Georg-August-Göttingen University (Germany) since 1997, and was additionally appointed to the position of Assistant Professor in 2003. Since 2006, he has also been Medical Director of the Tumor Cytogenetics Laboratory. His research and clinical focuses include prognostic factors, genetics and stem cell biology in acute myeloid...